Search
for
Sort by
Research 481–510 of 1000+
- Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
- Tofacitinib in the Management of Alopecia Universalis
- Targeted immunotherapy for hair regrowth and regeneration
- Hypohidrotic Ectodermal Dysplasia with c.28delG Mutation in Ectodysplasin A Gene and Severe Atopic Dermatitis Treated Successfully with Tofacitinib
- Risk of Safety Events in Vitiligo Patients: A Retrospective Real‐World Data Study in the US
- Successful Treatment of Canities Subita with Baricitinib
- Efficacy and Safety of Ritlecitinib in Alopecia Areata: A Systematic Review and Meta-Analysis (Preprint)
- British Association of Dermatologists living guideline for managing people with alopecia areata 2024
- Refractory dermatomyositis–systemic lupus erythematosus overlap syndrome and response to tofacitinib
- Acral Vitiligo: A Comprehensive Review of Clinical Features, Pathogenesis, and Novel Therapeutic Advances
- Deuruxolitinib for Alopecia Areata.
- Evolving treatment paradigms in dermatology: Insights from emerging and repurposed therapies
- Evaluating Scarring Alopecia Therapies from the Patient Perspective: Knowledge, Barriers to Care, and Treatment Satisfaction
- Alopecia areata: recognition, diagnosis and management
- Alopecia universalis following human papillomavirus vaccine administration: a case report
- DEVELOPING NEW DUAL-ACTION ANTIVIRAL/ANTI-INFLAMMATORY SMALL MOLECULES FOR COVID-19 TREATMENT USING IN SILICO AND IN-VITRO APPROACHES
- Treatment of Refractory Segmental Vitiligo and Alopecia Areata in a Child with Upadacitinib and NB-UVB: A Case Report
- JAK kinase pathway inhibitor drugs in patients with moderate-to-severe alopecia: a real-world experience
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Ritlecitinib: First Approval
- Keratosis Pilaris-like Eruption during Treatment of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors: Literature Review and Report of a Case Related to Imatinib
- Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
- Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis
- Learning from nudity: lessons from the nude phenotype
- Moving Beyond Boundaries: Utilization of Longitudinal Exposure–Response Model for Bounded Outcome Score to Inform Decision Making in the Accelerated Drug Development Paradigm
- 801 TEC family kinase inhibitors as a novel class of therapeutics in alopecia areata
- La FDA aprueba Litfulo® (ritlecitinib) para el tratamiento de la alopecia areata grave en adolescentes y adultos
- Impacto del desequilibrio del microbioma del cuero cabelludo en la severidad de la alopecia areata, marcadores inflamatorios y cambios post-tratamiento
- Mathematical Modeling and Inference of Epidermal Growth Factor-Induced Mitogen-Activated Protein Kinase Cell Signaling Pathways
- Platycladus orientalis Leaf Extract Promotes Hair Growth via Non-Receptor Tyrosine Kinase ACK1 Activation